KCa3.1 inhibition or gene deletion reduced dopaminergic (DA) neuron loss and improved the locomotor ability reducing microgliosis-mediated neuroinflammatory cytokine production in a mouse model of PD [103]. Here, KCNN4 is linked to Parkinson disease.